Overview

Staccato Prochlorperazine in Migraine (in Clinic)

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
Development of Staccato Prochlorperazine for the treatment of migraine headache.
Phase:
Phase 2
Details
Lead Sponsor:
Alexza Pharmaceuticals, Inc.
Treatments:
Prochlorperazine